Thermo Fisher Scientific

+$3.43 (+0.6%)
Closing price March 27, 2023
Here are five top health care stocks that provide investors with different avenues to invest in the sector. They all should be solid additions to growth portfolios for 2019.
The top analyst upgrades, downgrades and initiations seen on Thursday included AT&T, Boeing, Hilton, KB Home, Microsoft, Norfolk Southern, Pandora and UPS.
Here are the 15 companies that appear most likely to enter or get back into the $100 billion market capitalization club among U.S. stocks.
Managers of the UBS Q-GARP portfolio continue searching for high-quality U.S. growth companies that are trading at attractive valuations. They maintain that recent volatility in the market has had no...
According to a recent analyst report by Janney, the National Institute of Health budget that was approved last Friday could be a big boost for some select biopharma stocks.
According to Merrill Lynch, the health care sector should act as a good hedge against volatility. Even biotech was shown to offer growth at a reasonable price.
The include BioCryst Pharmaceuticals, Exxon Mobil, Fiat Chrysler Automobiles, Hewlett Packard Enterprise, IAMGOLD, Mallinckrodt and Rockwell Collins.
The top analyst upgrades, downgrades and other research calls from Tuesday include Alibaba, Best Buy, Deere, Jinko Solar, Motorola Solutions, Mylan, Redfin and VMware.
The top analyst upgrades, downgrades and other research calls from Friday include Autodesk, IBM, Lumber Liquidators, NVIDIA,, Symantec, T-Mobile and Wal-Mart.
Pantheon shares saw a huge gain on Monday following the announcement that the company will be acquired by Thermo Fisher Scientific.
Thermo Fisher Scientific said Friday morning that it has agreed to acquire FEI for approximately $4.2 billion in cash.
These biotech companies stood out from the rest with big moves over the course of the past week.
Affymetrix was absolutely soaring early on Monday on word that it will be acquired. Thermo Fisher Scientific is the buyer.
Tuesday’s top analyst upgrades, downgrades and initiations include CBS, Cisco, Comerica, Twitter, FedEx, Illumina, Linn Energy and NuVasive.
The unexpected reimbursement rate proposals by the Center for Medicaid hit the diagnostic sector on Monday.